ConductScience.org, home

Paper31409554

The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner.

Zhang Y and 4 others. Phytomedicine, 2021. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner. Papers, record 31409554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31409554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner.
PubMed
Journal
Phytomedicine
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
2.65
iCite
Revised in PubMed
2026-01-27
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang YYing
2Gilmour AAmy
3Ahn YHYoung-Hoon
4de la Vega LLaureano
5Dinkova-Kostova ATAlbena T

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
IsothiocyanatesMajor topic
NF-E2-Related Factor 2Major topic
SulfoxidesMajor topic
TOR Serine-Threonine KinasesMajor topic
Animals
Cell Line, Tumor
Humans
Phosphatidylinositol 3-Kinases
Phosphorylation
Proto-Oncogene Proteins c-akt

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
10270Cancer Research UKUnited KingdomPubMed
18644Cancer Research UKUnited KingdomPubMed
22869Cancer Research UKUnited KingdomPubMed

Source PubMed

Download CSV of grants

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125323681Suppression of feedback loops mediated by PI3K/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance.Mol Cancer Ther2014https://conductscience.org/library/papers/25323681PubMed
216280330Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.Carcinogenesis2006https://conductscience.org/library/papers/16280330PubMed
327075683A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet.Sci Rep2016https://conductscience.org/library/papers/27075683PubMed
424322890Sulphoxythiocarbamates modify cysteine residues in HSP90 causing degradation of client proteins and inhibition of cancer cell proliferation.Br J Cancer2014https://conductscience.org/library/papers/24322890PubMed
528692050Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses.Oncogene2017https://conductscience.org/library/papers/28692050PubMed
629242678KEAP1 and Done? Targeting the NRF2 Pathway with Sulforaphane.Trends Food Sci Technol2017https://conductscience.org/library/papers/29242678PubMed
730856464Sulforaphane triggers a functional elongation of microglial process via the Akt signal.J Nutr Biochem2019https://conductscience.org/library/papers/30856464PubMed
822640870Sulforaphane, a cruciferous vegetable-derived isothiocyanate, inhibits protein synthesis in human prostate cancer cells.Biochim Biophys Acta2012https://conductscience.org/library/papers/22640870PubMed
917914583Sulforaphane induces cell cycle arrest and apoptosis in murine osteosarcoma cells in vitro and inhibits tumor growth in vivo.Oncol Rep2007https://conductscience.org/library/papers/17914583PubMed
1017643370HDAC6 modulates cell motility by altering the acetylation level of cortactin.Mol Cell2007https://conductscience.org/library/papers/17643370PubMed
1117287208Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity.J Biol Chem2007https://conductscience.org/library/papers/17287208PubMed
1214585973Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress.Mol Cell Biol2003https://conductscience.org/library/papers/14585973PubMed
138910387Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase.J Biol Chem1996https://conductscience.org/library/papers/8910387PubMed
1416571651Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells.Carcinogenesis2006https://conductscience.org/library/papers/16571651PubMed
1510567225Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.Biochem J1999https://conductscience.org/library/papers/10567225PubMed
1628212891Sulforaphane inhibits platelet-derived growth factor-induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation.Pharmacol Res2017https://conductscience.org/library/papers/28212891PubMed
1717347138Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast.Carcinogenesis2007https://conductscience.org/library/papers/17347138PubMed
1823254561Effectiveness of sulforaphane as a radiosensitizer for murine osteosarcoma cells.Oncol Rep2013https://conductscience.org/library/papers/23254561PubMed
1924405297Sulforaphane induces DNA damage and mitotic abnormalities in human osteosarcoma MG-63 cells: correlation with cell cycle arrest and apoptosis.Nutr Cancer2014https://conductscience.org/library/papers/24405297PubMed
207826396Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases.Biochem Biophys Res Commun1995https://conductscience.org/library/papers/7826396PubMed

See all 33 referencesDownload CSV of references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
42939845Sulforaphane as a Therapeutic Target for Sarcopenia in Type 2 Diabetes: Mechanistic Insights and Translational Evidence.Antioxidants (Basel)2026https://conductscience.org/library/papers/42939845PubMed
42821033Machine learning for discovering anticancer compounds from plants and elucidating their mechanisms.J Comput Aided Mol Des2026https://conductscience.org/library/papers/42821033PubMed
42654274Sulforaphane Decreases the Burden of AKT1-Expressing Pre-Neoplastic Cells in a Zebrafish Model of Glioblastoma Initiation.Nutrients2026https://conductscience.org/library/papers/42654274PubMed
42653741Sulforaphane and Broccoli-Derived Preparations in Obesity and Obesity-Related Metabolic Dysfunction: Mechanistic Insights, Preclinical Evidence, and Clinical Perspectives.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42653741PubMed
42123607Sulforaphane-Activated Functional Nucleic Acids for Cancer Therapy: Mechanisms, Delivery Strategies, and Nanomedicine Advances.Int J Mol Sci2026https://conductscience.org/library/papers/42123607PubMed
41837504Targeting the mTOR Pathway with Natural Products: A Potential Therapeutic Approach for Autism Spectrum Disorders.Curr Neuropharmacol2026https://conductscience.org/library/papers/41837504PubMed
41768239Manganese modulates hepatocellular carcinoma cytotoxicity and doxorubicin sensitivity in a dose dependent manner.Front Oncol2026https://conductscience.org/library/papers/41768239PubMed
41275316
Investigating the clinical efficacy, safety and molecular mechanism of sulforaphane in autism spectrum disorder: an integrated study combining meta-analysis, network pharmacology, and computational biology.
BMC Pharmacol Toxicol2025https://conductscience.org/library/papers/41275316PubMed
41196460Sulforaphane: a natural organosulfur having potential to modulate apoptosis and survival signalling in cancer.Discov Oncol2025https://conductscience.org/library/papers/41196460PubMed
40676702The dual role of mTOR signaling in lung development and adult lung diseases.Cell Biosci2025https://conductscience.org/library/papers/40676702PubMed
39765789The Effect of Moringa oleifera Leaf Extract on C2C12 Myoblast Proliferation and Redox Status Under Oxidative Insult.Antioxidants (Basel)2024https://conductscience.org/library/papers/39765789PubMed
39334742Multiple Mechanisms of Action of Sulfodyne®, a Natural Antioxidant, against Pathogenic Effects of SARS-CoV-2 Infection.Antioxidants (Basel)2024https://conductscience.org/library/papers/39334742PubMed
39199250Activation of Nrf2 at Critical Windows of Development Alters Tissue-Specific Protein S-Glutathionylation in the Zebrafish (Danio rerio) Embryo.Antioxidants (Basel)2024https://conductscience.org/library/papers/39199250PubMed
39139965Sulforaphane and ophthalmic diseases.Food Sci Nutr2024https://conductscience.org/library/papers/39139965PubMed
39125678Comparative Metabolomic Analysis of Moringa oleifera Leaves of Different Geographical Origins and Their Antioxidant Effects on C2C12 Myotubes.Int J Mol Sci2024https://conductscience.org/library/papers/39125678PubMed
38902597Potential mechanisms of cancer prevention and treatment by sulforaphane, a natural small molecule compound of plant-derived.Mol Med2024https://conductscience.org/library/papers/38902597PubMed
38868980Sulforaphane enhanced muscle growth by promoting lipid oxidation through modulating key signaling pathways.Biosci Rep2024https://conductscience.org/library/papers/38868980PubMed
36838876mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder.Molecules2023https://conductscience.org/library/papers/36838876PubMed
36500494The Multiple Sclerosis Modulatory Potential of Natural Multi-Targeting Antioxidants.Molecules2022https://conductscience.org/library/papers/36500494PubMed
36284193Synthesis and Anti-Inflammatory Activity of 2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophene-Derived NRF2 Activators.ChemistryOpen2022https://conductscience.org/library/papers/36284193PubMed

See all 30 cited byDownload CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31409554

GET https://conductscience.org/api/papers/v1/31409554/references?page=2